(Q35810123)

10 August 2017

1 reference

title

Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature (English)

1 reference

10 August 2017

0 references

hepatocellular carcinoma

1 reference

Lun-Xiu Qin

1

1 reference

PubMed ID

15205947

10 August 2017

Zhao-You Tang

series ordinal

2

1 reference

PubMed ID

15205947

10 August 2017

language of work or name

1 reference

17 June 2004

1 reference

Journal of Cancer Research and Clinical Oncology

10 August 2017

1 reference

10 August 2017

130

1 reference

10 August 2017

497-513

1 reference

10 August 2017

9

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-004-0572-9

10 August 2017

0 references

cites work

Multicenter prospective analysis of newly diagnosed hepatocellular carcinoma with respect to the percentage of Lens culinaris agglutinin-reactive alpha-fetoprotein1

1 reference

12 December 2020

Usefulness of measurement of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and recurrence of small hepatocellular carcinoma

1 reference

12 December 2020

Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence

1 reference

12 December 2020

Clinical implications of circulating angiogenic factors in cancer patients

1 reference

12 December 2020

The functional and clinical roles of osteopontin in cancer and metastasis.

1 reference

12 December 2020

Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas

1 reference

12 December 2020

A study on angiogenesis-related matrix metalloproteinase networks in primary hepatocellular carcinoma

1 reference

12 December 2020

Identify metastasis-associated genes in hepatocellular carcinoma through clonality delineation for multinodular tumor

1 reference

12 December 2020

Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levels

1 reference

12 December 2020

Expression of E-cadherin in squamous cell carcinomas of the supraglottic larynx with correlations to clinicopathological features

1 reference

12 December 2020

Prognostic value of CD44 expression in colorectal carcinomas

1 reference

12 December 2020

Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling

1 reference

12 December 2020

Prognostic impact of matrix metalloproteinase-9 in operable non-small cell lung cancer

1 reference

12 December 2020

The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma

1 reference

12 December 2020

Assessment of the clinical significance of serum matrix metalloproteinases MMP-2 and MMP-9 in patients with various chronic liver diseases and hepatocellular carcinoma.

1 reference

12 December 2020

Expression of the gamma(2) chain of laminin-5 at the invasive front is associated with recurrence and poor prognosis in human esophageal squamous cell carcinoma

1 reference

12 December 2020

Serum vascular endothelial growth factor is a predictor of invasion and metastasis in hepatocellular carcinoma

1 reference

12 December 2020

Prognostic significance of P53 histochemistry and DNA histogram parameters in head and neck malignancies

1 reference

12 December 2020

Prognostic impact of multiple allelic losses on metastatic recurrence in hepatocellular carcinoma after curative resection

1 reference

12 December 2020

Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy

1 reference

12 December 2020

Proteomic profiling from human samples: the body fluid alternative

1 reference

12 December 2020

Genomic analysis of metastasis reveals an essential role for RhoC

1 reference

12 December 2020

Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?

1 reference

12 December 2020

RECK gene expression in hepatocellular carcinoma: correlation with invasion-related clinicopathological factors and its clinical significance. Reverse-inducing--cysteine-rich protein with Kazal motifs

1 reference

12 December 2020

Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma

1 reference

12 December 2020

Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interest

1 reference

12 December 2020

Invasion and metastasis of liver cancer: expression of intercellular adhesion molecule 1

1 reference

12 December 2020

Prognostic value of vascular endothelial growth factor in breast cancer

1 reference

12 December 2020

Cytoplasmic expression of laminin gamma2 chain correlates with postoperative hepatic metastasis and poor prognosis in patients with pancreatic ductal adenocarcinoma

1 reference

12 December 2020

Circulating DNA in plasma or serum.

1 reference

12 December 2020

Prognostic impact of cathepsin B and matrix metalloproteinase-9 in pulmonary adenocarcinomas by immunohistochemical study

1 reference

12 December 2020

Clinical significance of p53 mutations in adenocarcinoma of the esophagus and cardia

1 reference

12 December 2020

Molecular mechanisms of glioma invasiveness: the role of proteases

1 reference

12 December 2020

Proliferating cell nuclear antigen, p53, and c-erbB-2 expression in relation to clinicopathological variables and prognosis in cancer of the ampulla of Vater

1 reference

12 December 2020

Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment

1 reference

12 December 2020

Reduced CD44 standard expression is associated with tumour recurrence and unfavourable outcome in differentiated thyroid carcinoma

1 reference

12 December 2020

A molecular signature of metastasis in primary solid tumors

1 reference

12 December 2020

Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver

1 reference

12 December 2020

Molecular signature associated with bone marrow micrometastasis in human breast cancer

1 reference

12 December 2020

Biological and clinical relevance of Laminin-5 in cancer

1 reference

12 December 2020

Distinct prognostic values of p53 mutations and loss of estrogen receptor and their cumulative effect in primary breast cancers

1 reference

12 December 2020

Preoperative prostate needle biopsy p27 correlates with subsequent radical prostatectomy p27, Gleason grade and pathological stage

1 reference

12 December 2020

Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification

1 reference

12 December 2020

Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study

1 reference

12 December 2020

P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection

1 reference

12 December 2020

Diffuse mode of tumor cell invasion and expression of mutant p53 protein but not of p21 protein are correlated with treatment failure in oral carcinomas and their metastatic foci

1 reference

12 December 2020

Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas

1 reference

12 December 2020

p53 gene mutations are associated with shortened survival in patients with advanced non-small cell lung cancer: an analysis of medically managed patients

1 reference

12 December 2020

Prognostic value of the urokinase-type plasminogen activator, and its inhibitors and receptor in breast cancer patients

1 reference

12 December 2020

A High Cytosol Value of Urokinase-Type Plasminogen Activator (uPA) May Be Predictive of Early Relapse in Primary Breast Cancer

1 reference

12 December 2020

Telomerase activity as a predictive marker for recurrence of hepatocellular carcinoma after hepatectomy

1 reference

12 December 2020

Diagnostic clues for recurrent hepatocellular carcinoma: comparison of tumour markers and imaging studies.

1 reference

12 December 2020

Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.

1 reference

12 December 2020

Microvessel density of hepatocellular carcinoma: its relationship with prognosis

1 reference

12 December 2020

Possible contribution of CD44 variant 6 and nuclear beta-catenin expression to the formation of budding tumor cells in patients with T1 colorectal carcinoma

1 reference

12 December 2020

Molecular predictive factors for local recurrence and distant metastasis of breast cancer after lumpectomy with postoperative radiation therapy

1 reference

12 December 2020

Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs

1 reference

12 December 2020

Deranged expression of the E-cadherin/beta-catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas

1 reference

12 December 2020

P53 determination alongside classical prognostic factors in node-negative breast cancer: an evaluation at more than 10-year follow-up

1 reference

12 December 2020

Circulating angiogenesis regulators in cancer patients.

1 reference

12 December 2020

Adhesion molecules as prognostic factors in nasopharyngeal carcinoma.

1 reference

12 December 2020

Gene expression profiling predicts clinical outcome of breast cancer

1 reference

12 December 2020

Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma

1 reference

12 December 2020

u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma

1 reference

12 December 2020

Clinical application of quantitative analysis for detection of hematogenous spread of hepatocellular carcinoma by real-time PCR

1 reference

12 December 2020

Is the p53 gene mutation of prognostic value in hepatocellular carcinoma after resection?

1 reference

12 December 2020

The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression

1 reference

12 December 2020

p53 mutation in plasma DNA and its prognostic value in breast cancer patients

1 reference

12 December 2020

Relationship between p53 overexpression and the proliferative activity in hepatocellular carcinoma.

1 reference

12 December 2020

Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinoma

1 reference

12 December 2020

Development of a multiple-marker RT-PCR assay for detection of micrometastases of hepatocellular carcinoma

1 reference

12 December 2020

Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression.

1 reference

12 December 2020

Micrometastatic p53-positive cells in the lymph nodes of early stage epithelial ovarian cancer: prognostic significance.

1 reference

12 December 2020

Prognostic significance of circulating microsatellite markers in the plasma of melanoma patients.

1 reference

12 December 2020

Is p53 gene mutation an indicatior of the biological behaviors of recurrence of hepatocellular carcinoma?

1 reference

12 December 2020

Prognostic significance of matrix metalloproteinases 2 and 9 in bladder cancer

1 reference

12 December 2020

Evaluation of curability and prediction of prognosis after surgical treatment for hepatocellular carcinoma by lens culinaris agglutinin-reactive alpha-fetoprotein

1 reference

12 December 2020

Loss of heterozygosity at D14S62 and D14S51 detected by a simple and non-radioactive method in plasma DNA is a potential marker of metastasis and recurrence after curative hepatic resection in hepatocellular carcinoma

1 reference

12 December 2020

Absence of therapeutically relevant c-erbB-2 expression in human hepatocellular carcinomas

1 reference

12 December 2020

Effect of the presence of hepatitis B e antigen on prognosis after liver resection for hepatocellular carcinoma in patients with chronic hepatitis B

1 reference

12 December 2020

TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancer

1 reference

12 December 2020

Angiogenesis in hepatocellular carcinoma as evaluated by alpha smooth muscle actin immunohistochemistry

1 reference

12 December 2020

The role of osteopontin in breast cancer: clinical and experimental studies

1 reference

12 December 2020

Detection and prediction of micrometastasis in the lymph nodes of patients with pN0 gastric cancer

1 reference

12 December 2020

Oligodendroglioma: CD44 as a possible prognostic opportunity.

1 reference

12 December 2020

Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region

1 reference

12 December 2020

Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival

1 reference

12 December 2020

Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis.

1 reference

12 December 2020

Predictive survival markers in patients with surgically resected non-small cell lung carcinoma

1 reference

12 December 2020

Laminin-5 chains are expressed differentially in metastatic and nonmetastatic hepatocellular carcinoma

1 reference

12 December 2020

Laminin isoforms in tumor invasion, angiogenesis and metastasis

1 reference

12 December 2020

Expression of bile duct-type cytokeratin in hepatocellular carcinoma in patients with hepatitis C virus and prior hepatitis B virus infection

1 reference

12 December 2020

Prognostic value of serum biological markers in patients with hepatocellular carcinoma

1 reference

12 December 2020

Correlation of CD44S expression in renal clear cell carcinomas with subsequent tumor progression or recurrence

1 reference

12 December 2020

Successful prediction of prostate cancer recurrence by gene profiling in combination with clinical data: a 5-year follow-up study.

1 reference

12 December 2020

Prognostic value of MMP-2, -9 and TIMP-1,-2 immunoreactive protein at the invasive front in advanced head and neck squamous cell carcinomas

1 reference

12 December 2020

Multiplex Biomarker Approach for Determining Risk of Prostate-Specific Antigen-Defined Recurrence of Prostate Cancer

1 reference

12 December 2020

Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival

1 reference

12 December 2020

Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma

1 reference

12 December 2020

Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma

1 reference

12 December 2020

Serum Soluble Vascular Cell Adhesion Molecule-1: Role as a Surrogate Marker of Angiogenesis

1 reference

12 December 2020

Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis

1 reference

12 December 2020

Plasma MMP-9 (92 kDa-MMP) activity is useful in the follow-up and in the assessment of prognosis in breast cancer patients

1 reference

12 December 2020

Reduced E-cadherin expression and enlargement of cancer nuclei strongly correlate with hematogenic metastasis in colorectal adenocarcinoma

1 reference

12 December 2020

Prognostic significance of matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression in prostate cancer

1 reference

12 December 2020

Osteopontin and colon cancer progression

1 reference

12 December 2020

CD44 standard form expression as a predictor of progression in high risk superficial bladder tumors

1 reference

12 December 2020

Laminin-5 gamma2 chain expression as a possible determinant of tumor aggressiveness in T1 colorectal carcinomas

1 reference

12 December 2020

Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer

1 reference

12 December 2020

Decreased CD44H expression in early-stage tongue carcinoma associates with late nodal metastases following interstitial brachytherapy

1 reference

12 December 2020

Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas

1 reference

12 December 2020

alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study

1 reference

12 December 2020

Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer.

1 reference

12 December 2020

Abnormal beta-catenin gene expression with invasiveness of primary hepatocellular carcinoma in China

1 reference

12 December 2020

Overexpression of osteopontin in hepatocellular carcinoma

1 reference

12 December 2020

Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma.

1 reference

12 December 2020

Blood platelets and serum VEGF in cancer patients

1 reference

12 December 2020

The significance of p53 mutations as an indicator of the biological behavior of recurrent hepatocellular carcinomas

1 reference

12 December 2020

A comparative study of the clinicopathological significance of E-cadherin and catenins (α, β, γ) expression in the surgical management of oral tongue carcinoma

1 reference

12 December 2020

Analysis of loss of heterozygosity on chromosome 10 in patients with malignant astrocytic tumors: correlation with patient age and survival.

1 reference

12 December 2020

p53 status is neither a predictive nor a prognostic variable in patients with advanced ovarian cancer treated with a paclitaxel-based regimen

1 reference

12 December 2020

The mode of tumour progression in combined hepatocellular carcinoma and cholangiocarcinoma: an immunohistochemical analysis of E-cadherin, alpha-catenin and beta-catenin

1 reference

12 December 2020

Circulating tumor cell mRNAs in peripheral blood from hepatocellular carcinoma patients under radiotherapy, surgical resection or chemotherapy: a quantitative evaluation

1 reference

12 December 2020

Identification of high risk breast-cancer patients by gene expression profiling

1 reference

12 December 2020

Pitfalls in the measurement of circulating vascular endothelial growth factor

1 reference

12 December 2020

Enhanced expression of cyclin E and cyclin A in human hepatocellular carcinomas.

1 reference

12 December 2020

Immunohistochemical evaluation is not prognostic for recurrence in fully staged high-risk endometrial cancer

1 reference

12 December 2020

Prognostic significance of heat shock protein-27 expression in hepatocellular carcinoma and its relation to histologic grading and survival

1 reference

12 December 2020

Plasma osteopontin: associations with survival and metastasis to bone in men with hormone-refractory prostate carcinoma.

1 reference

12 December 2020

Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis

1 reference

12 December 2020

The prognostic significance of clinical and pathological features in hepatocellular carcinoma

1 reference

12 December 2020

8pter-p23 deletion is associated with racial differences in prostate cancer outcome

1 reference

12 December 2020

Outcome prediction with p53 immunostaining after radical prostatectomy in patients with locally advanced prostate cancer

1 reference

12 December 2020

Prognostic influence of p53 nuclear overexpression in colorectal carcinoma

1 reference

12 December 2020

Implication of laminin and collagen type IV expression in the progression of breast carcinoma.

1 reference

12 December 2020

The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years

1 reference

12 December 2020

Plasma matrix metalloproteinase-9 (gelatinase B) in patients with hepatocellular carcinoma

1 reference

12 December 2020

Relationship between expression of alpha-fetoprotein messenger RNA and some clinical parameters of human hepatocellular carcinoma

1 reference

12 December 2020

A new predictive factor for hepatocellular carcinoma based on two-dimensional electrophoresis of genomic DNA.

1 reference

12 December 2020

Telomerase activity in peripheral blood for diagnosis of hepatoma

1 reference

12 December 2020

Metastatic breast cancer with HER2/neu-positive cells tends to have a morbid prognosis

1 reference

12 December 2020

Elevated expression of valosin-containing protein (p97) in hepatocellular carcinoma is correlated with increased incidence of tumor recurrence.

1 reference

12 December 2020

Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells

1 reference

12 December 2020

The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma

1 reference

12 December 2020

Influence of tumor localization on the prognostic value of P53 protein in colorectal adenocarcinomas

1 reference

12 December 2020

Serum vascular endothelial growth factor is a potential biomarker of metastatic recurrence after curative resection of hepatocellular carcinoma.

1 reference

12 December 2020

Chromosome 8p deletion is associated with metastasis of human hepatocellular carcinoma when high and low metastatic models are compared

1 reference

12 December 2020

Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer

1 reference

12 December 2020

Expression of p53 and p21waf1/cip1 in gastric carcinoma: lack of inter-relationship or correlation with prognosis

1 reference

12 December 2020

Beta-catenin expression in hepatocellular carcinoma: a possible participation of beta-catenin in the dedifferentiation process

1 reference

12 December 2020

Allelic imbalance regions on chromosomes 8p, 17p and 19p related to metastasis of hepatocellular carcinoma: comparison between matched primary and metastatic lesions in 22 patients by genome-wide microsatellite analysis.

1 reference

12 December 2020

Overexpression of MMP-9 correlates with growth of small hepatocellular carcinoma

1 reference

12 December 2020

Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor

1 reference

12 December 2020

Circulating VEGF levels in the serum of gastric cancer patients: correlation with pathological variables, patient survival, and tumor surgery

1 reference

12 December 2020

Acquired expression of p27 is a favorable prognostic indicator in patients with hepatocellular carcinoma

1 reference

12 December 2020

HER-2/neu gene product in serum--an oncoprotein in the diagnosis and therapy of breast carcinoma.

1 reference

12 December 2020

Molecular markers are predictors of recurrence and survival in patients with Dukes B and Dukes C colorectal adenocarcinoma

1 reference

12 December 2020

p53 and bcl-2 immunohistochemistry in pretreatment prostate needle biopsies to predict recurrence of prostate cancer after radical prostatectomy

1 reference

12 December 2020

Abnormal E-cadherin expression and prostate cell blood dissemination as markers of biological recurrence in cancer

1 reference

12 December 2020

Matrix metalloproteinase (MMP) expression by differentiated thyroid carcinoma of children and adolescents

1 reference

12 December 2020

Postoperative detection of alpha-fetoprotein mRNA in blood as a predictor for metastatic recurrence of hepatocellular carcinoma

1 reference

12 December 2020

Enhanced expression of matrix metalloproteinase-9 by hepatitis B virus infection in liver cells

1 reference

12 December 2020

The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinoma

1 reference

12 December 2020

Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma.

1 reference

12 December 2020

Real-time quantification of AFP mRNA to assess hematogenous dissemination after transarterial chemoembolization of hepatocellular carcinoma

1 reference

12 December 2020

Evaluation of cytokeratin-19 mRNA as a tumor marker in the peripheral blood of nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy.

1 reference

12 December 2020

Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma.

1 reference

12 December 2020

Expression profiling of blood samples from an SU5416 Phase III metastatic colorectal cancer clinical trial: a novel strategy for biomarker identification

1 reference

12 December 2020

Prognostic significance of glutamine synthetase expression in unifocal advanced hepatocellular carcinoma

1 reference

12 December 2020

The challenge of p53 as prognostic and predictive factor in Hodgkin's or non-Hodgkin's lymphoma

1 reference

12 December 2020

1 reference

12 December 2020

Monitoring of p53 autoantibodies after resection of colorectal cancer: relationship to operative curability

1 reference

12 December 2020

Elevated serum pro-MMP2 levels in patients with stage IV thymoma

1 reference

12 December 2020

E-cadherin as a prognostic indicator in primary breast cancer

1 reference

12 December 2020

Prognostic factors in tongue cancer - relative importance of demographic, clinical and histopathological factors

1 reference

12 December 2020

Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma

1 reference

12 December 2020

Preoperative plasma levels of transforming growth factor beta(1) strongly predict clinical outcome in patients with bladder carcinoma

1 reference

12 December 2020

Expression of MAGE genes and survival in patients with hepatocellular carcinoma

1 reference

12 December 2020

Moving toward an understanding of the metastatic process in hepatocellular carcinoma

1 reference

12 December 2020

Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning

1 reference

12 December 2020

Degradation of tenascin-C and activity of matrix metalloproteinase-2 are associated with tumor recurrence in early stage non-small cell lung cancer

1 reference

12 December 2020

Presence of alpha-fetoprotein mRNA in blood correlates with outcome in patients with hepatocellular carcinoma

1 reference

12 December 2020

Discovery and analysis of hepatocellular carcinoma genes using cDNA microarrays

1 reference

12 December 2020

beta-catenin signaling and cancer

1 reference

12 December 2020

Allelic losses of loci at 3p25.1, 8p22, 13q12, 17p13.3, and 22q13 correlate with postoperative recurrence in breast cancer

1 reference

12 December 2020

Gene expression predictors of breast cancer outcomes

1 reference

12 December 2020

Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma.

1 reference

12 December 2020

Correlation of E-cadherin expression and recurrence of hepatocellular carcinoma

1 reference

12 December 2020

Quantitative comparison of alpha-fetoprotein and albumin mRNA levels in hepatocellular carcinoma/adenoma, non-tumor liver and blood: implications in cancer detection and monitoring

1 reference

12 December 2020

Clinicopathologic features of patients with hepatocellular carcinoma seropositive for alpha-fetoprotein-L3 and seronegative for des-gamma-carboxy prothrombin in comparison with those seropositive for des-gamma-carboxy prothrombin alone

1 reference

12 December 2020

Allelic loss of chromosome 2p21-16.3 is associated with reduced survival in sporadic colorectal cancer

1 reference

12 December 2020

Carriage of HFE mutations and outcome of surgical resection for hepatocellular carcinoma in cirrhotic patients

1 reference

12 December 2020

Immunohistochemical detection of E-cadherin, alpha- and beta-catenins in papillary thyroid carcinoma

1 reference

12 December 2020

Prognostic value of p53 for local failure in mastectomy-treated breast cancer patients

1 reference

12 December 2020

A gene-expression signature as a predictor of survival in breast cancer

1 reference

12 December 2020

AFP-L3: a new generation of tumor marker for hepatocellular carcinoma.

1 reference

12 December 2020

Micrometastasis in the bone marrow of patients with lung cancer associated with a reduced expression of E-cadherin and beta-catenin: risk assessment by immunohistochemistry

1 reference

12 December 2020

Expression of osteopontin and vascular endothelial growth factor in benign and malignant bone tumors

1 reference

12 December 2020

Determination of the oncogenes p53 and C-erb B2 in the tumour cytosols of advanced hepatocellular carcinoma (HCC) and correlation to survival time.

1 reference

12 December 2020

Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method

1 reference

12 December 2020

Interstitial collagenases as markers of tumor progression

1 reference

12 December 2020

Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival

1 reference

12 December 2020

Amplification of c-myc in hepatocellular carcinoma: correlation with clinicopathologic features, proliferative activity and p53 overexpression

1 reference

12 December 2020

Detection of MUC1 and keratin 19 mRNAs in the bone marrow by quantitative RT-PCR predicts the risk of distant metastasis in breast cancer patients.

1 reference

12 December 2020

MIB-1, p53, bcl-2, and WAF-1 expression in pelvic lymph nodes and primary tumors in early stage cervical carcinomas: correlation with clinical outcome

1 reference

12 December 2020

beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance.

1 reference

12 December 2020

Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.

1 reference

12 December 2020

Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma

1 reference

12 December 2020

Laminin-5 in the progression of carcinomas

1 reference

12 December 2020

Prognostic significance of dysadherin expression in advanced colorectal carcinoma

1 reference

12 December 2020

Prognostic significance of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin in patients with resectable hepatocellular carcinoma after surgery

1 reference

12 December 2020

Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma

1 reference

12 December 2020

Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study

1 reference

12 December 2020

Circulating tumor-derived DNA may permit the early diagnosis of head and neck squamous cell carcinomas

1 reference

12 December 2020

Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients

1 reference

12 December 2020

Altered expression of E-cadherin in breast cancer

1 reference

12 December 2020

Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence

1 reference

12 December 2020

Clinical significance of urokinase-type plasminogen activator activity in hepatocellular carcinoma

1 reference

12 December 2020

p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer.

1 reference

12 December 2020

p53 tumor suppressor gene mutations predict decreased survival of patients with sporadic colorectal carcinoma.

1 reference

12 December 2020

Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum

1 reference

12 December 2020

Identification of potential biomarkers of lymph node metastasis in oral squamous cell carcinoma by cDNA microarray analysis.

1 reference

12 December 2020

Prognostic significance of p53 nuclear accumulation in localized prostate cancer treated with radical prostatectomy

1 reference

12 December 2020

Excretion of matrix metalloproteinases 2 and 9 in urine is associated with a high stage and grade of bladder carcinoma

1 reference

12 December 2020

A prospective trial of midwest breast cancer patients: a p53 gene mutation is the most important predictor of adverse outcome.

1 reference

12 December 2020

Prognostic impact of P53 status in Ewing sarcoma

1 reference

12 December 2020

Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma

1 reference

12 December 2020

CD44 isoform expression in synovial sarcoma correlates with epitheliogenesis but not prognosis

1 reference

12 December 2020

p53 nuclear accumulation is not associated with decreased disease-free survival in patients with node positive transitional cell carcinoma of the bladder

1 reference

12 December 2020

Hepatitis viral status in patients undergoing liver resection for hepatocellular carcinoma

1 reference

12 December 2020

Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder

1 reference

12 December 2020

Cloning and characterization of a novel gene, DRH1, down-regulated in advanced human hepatocellular carcinoma

1 reference

12 December 2020

Expression and prognostic role of cyclin-dependent kinase 1 (cdc2) in hepatocellular carcinoma

1 reference

12 December 2020

10.1007/S00432-004-0572-9

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15205947